gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NYSE · TFXHealthcareSurgical Instruments

Teleflex Incorporated (TFX)

$149.87+7.09%
Close Nov 4, 2026 · split-adjusted
Oct 30, 2026$139.77▲ 13.77% in range
Nov 3, 2025Low $100.34 · High $142.05Oct 30, 2026
What changed · written from our data
As of Nov 4, 2026

Teleflex Incorporated closed at $149.87 on Nov 4, up 7.09% — matching its 52-week closing high. Volume of 1.3M shares was 1.73× its 20-day average (above normal).

Split-adjusted performance: +20.1% over one month, +21.6% over six months, +22.0% over one year.

In the quarter ended Jun 30, 2026, revenue was $570.33M, up 28.9% from a year earlier, with a net margin of 17.5%.

Short interest was 4.2M shares at the Oct 15 settlement, up 4.1% from the prior report (10.2% of float, 6.0 days to cover).

Market cap$6.35B42.4M shares
Revenue · quarter$570.3M+28.9% YoY
Diluted EPS$2.28−17.7% YoY
P/E · TTM—
Net margin17.5%Gross 58.2%
Dividend yield0.91%$0.34 last paid
52-week range100.34 – 149.870.0% from high
Volume1.3M1.73× 20-day avg
Volatility · 60d28.4%Annualised
Short % of float10.2%6.0 days to cover
Net cash-$2.51BCash $300.2M
Next earnings—Not scheduled
Split-adjusted performance
1W +7.8%1M +20.1%3M +7.9%6M +21.6%YTD +22.8%1Y +22.0%3Y −16.5%5Y −59.1%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum68
Revenue growth85
Net margin88
Value (low P/E)—
Size87

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short4.2M+4.1% vs prior
Days to cover6.0Settled Oct 15
% of float10.2%
Short vol. 10d62.5%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
TFXTeleflex Incorporated$149.87+7.09%+21.6%+28.9%17.5%—$6.35B
HAEHaemonetics$127.42+5.94%+141.9%+5.6%9.7%60.2$5.80BCompare
MMSIMerit Medical Systems$90.63+7.69%+47.1%+8.4%10.2%33.9$5.43BCompare
MMEDMiniMed Group$19.29+2.33%——0.0%—$5.43BCompare
HTFLHeartflow$56.57+3.99%+86.8%—−24.6%—$4.92BCompare
IRTCiRhythm Holdings$134.00+6.04%+13.8%+20.1%−0.2%—$4.42BCompare
ICUIICU Medical$172.62+6.67%+44.3%+0.5%3.5%143.5$4.32BCompare
PLSEPulse Biosciences, Inc Common Stock (DE)$57.06+9.31%+197.0%—−5681.3%—$4.07BCompare
PODDInsulet$165.02+6.56%+9.1%+23.5%11.8%30.5$11.44BCompare

News about Teleflex Incorporated

All news →
TFX or SONVY: Which Is the Better Value Stock Right Now?Zacks Investment Research · Oct 6, 2026▲ PositiveIs It Prudent to Add Teleflex Stock to Your Portfolio Now?Zacks Investment Research · Oct 6, 2026NeutralShould You Add Teleflex Stock to Your Portfolio Now?Zacks Investment Research · Aug 28, 2026▲ PositiveFDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.GlobeNewswire Inc. · Jul 29, 2026▲ PositiveTeleflex Investors to Put a Lost Decade BehindInvesting.com · May 19, 2026▲ Positive

Quick answers

What does Teleflex Incorporated do?
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures.
What is TFX's market cap?
$6.35B, based on the Nov 4 close of $149.87.
Does Teleflex Incorporated pay a dividend?
Yes. The latest regular dividend was $0.34 per share (ex-date Aug 14), an annualised yield of 0.91%.
How much of TFX is sold short?
4.2M shares, 10.2% of float, as of Oct 15, 2026.
What sector is TFX in?
Healthcare, in the Surgical Instruments industry.

About Teleflex Incorporated

Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.

HQ: Wayne, PA15,500 employeesListed Jun 1, 1972teleflex.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology